Draft Guidance for Industry and Investigators: Safety Reporting Requirements for Investigational New Drug Applications andBioavailability/Bioequivalence Studies; Availability
Title: Baxter Healthcare Corporation - Comment
Baxter Healthcare Corporation - Comment
This is comment on Notice
Draft Guidance for Industry and Investigators: Safety Reporting Requirements for Investigational New Drug Applications andBioavailability/Bioequivalence Studies; Availability
View Comment
Attachments:
Baxter Healthcare Corporation - Comment
Title:
Baxter Healthcare Corporation - Comment
Related Comments
View AllPublic Submission Posted: 11/19/2010 ID: FDA-2010-D-0482-0002
Dec 28,2010 11:59 PM ET
Public Submission Posted: 11/29/2010 ID: FDA-2010-D-0482-0003
Dec 28,2010 11:59 PM ET
Public Submission Posted: 12/17/2010 ID: FDA-2010-D-0482-0004
Dec 28,2010 11:59 PM ET
Public Submission Posted: 12/21/2010 ID: FDA-2010-D-0482-0006
Dec 28,2010 11:59 PM ET
Public Submission Posted: 12/21/2010 ID: FDA-2010-D-0482-0007
Dec 28,2010 11:59 PM ET